News
There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.
WHAT WE FOUND There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.
WHAT WE FOUND There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.
WHAT WE FOUND There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.
WHAT WE FOUND There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.
There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.
There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.
Three insulin products are currently in shortage, but all other insulin products are in good supply, including alternatives for the limited products.
There is currently a shortage for Levemir and for some generic Insulin Aspart and brand-name Novolog products. There are no other ongoing reported insulin shortages as of Nov. 16, 2023.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback